相关实验视频
Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
实施个性化癌症医学:从定性访谈研究的见解
Michele Masucci1,2, Jenny Del Villar Pérez2, Pamela Mazzocato2
1Department of Microbiology Tumor and Cell Biology (MTC), Karolinska Institutet, Biomedicum Q8C, Solnavägen 9, 171 65 Solna, Sweden.
个性化癌症医学 (PCM) 面临着由于组织和系统障碍的实施挑战. 克服这些需要多方利益相关者的合作和适应性战略,以有效地融入临床实践.
科学领域:
- 在瘤学瘤学.
- 医疗保健管理的管理
- 基因组学就是基因组学.
背景情况:
- 个性化癌症医学 (PCM) 提供基于遗传特征的量身定制治疗.
- 整合到临床实践中受到组织和系统障碍的阻碍.
- 这项研究调查了瑞典一家领先的癌症中心的PCM实施因素.
研究的目的:
- 确定影响个性化癌症医学实施的障碍和促进因素.
- 探索医疗保健专业人员和管理层对PCM整合的观点.
- 为在临床环境中成功采用PCM的策略提供信息.
主要方法:
- 与16名医疗专业人员和管理人员进行了半结构化采访.
- 使用内容分析来确定与PCM实施相关的关键主题.
- 定性研究指南 (COREQ) 确保了方法的严格性.
主要成果:
- PCM被视为一种技术创新和以患者为中心的方法.
- 确定的障碍包括组织惯性,资金碎片化和股权问题.
- 促进者包括领导力承诺,跨部门合作和支持性政策.
结论:
- 成功实施PCM需要通过多方利益相关者的协作克服系统性障碍.
- 建议建立一个"第三形式组织",将学术界和临床护理联系起来.
- 适应性治理,政策改革和可持续融资对于PCM整合至关重要.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...